Development and validation of an interpretable machine learning model for predicting progression-free survival after immunotherapy in patients with non-small cell lung cancer: a multicenter study
Year: 2025
Type: article
Language: en
Topic: Cancer Immunotherapy and Biomarkers
Authors and affiliations:
raw_author_name: Ya Li
raw_affiliation_strings: Department of Oncology, Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, China
Department of Oncology, Affiliated Hospital of Guizhou Medical University, Guiyang, China
Department of Oncology, The Second Affiliated Hospital of Guizhou Medical University, Kaili, China
Division of Oncology, School of Clinical Medicine, Guizhou Medical University, Guiyang, China
raw_author_name: Ji Xia
raw_affiliation_strings: Department of Oncology, Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, China
Department of Oncology, Affiliated Hospital of Guizhou Medical University, Guiyang, China
Department of Oncology, The Second Affiliated Hospital of Guizhou Medical University, Kaili, China
Division of Oncology, School of Clinical Medicine, Guizhou Medical University, Guiyang, China
raw_author_name: Tianchu He
raw_affiliation_strings: Department of Oncology, Qiandongnan Prefecture People's Hospital, Kaili, China
raw_author_name: Yong Hu
raw_affiliation_strings: Department of Oncology, Guiyang Pulmonary Hospital, Guiyang, China
raw_author_name: Daobin Zhou
raw_affiliation_strings: Department of Oncology, Qiandongnan Prefecture People's Hospital, Kaili, China
raw_author_name: Dan Zou
raw_affiliation_strings: Department of Oncology, The Second Affiliated Hospital of Guizhou Medical University, Kaili, China
raw_author_name: Benlan Li
raw_affiliation_strings: Department of Oncology, Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, China
Department of Oncology, Affiliated Hospital of Guizhou Medical University, Guiyang, China
Department of Oncology, The Second Affiliated Hospital of Guizhou Medical University, Kaili, China
Division of Oncology, School of Clinical Medicine, Guizhou Medical University, Guiyang, China
raw_author_name: Min Zhang
raw_affiliation_strings: Department of Oncology, Dujiangyan Shoujia Hospital, Chengdu, China
Department of Oncology, Panzhou People's Hospital, Liupanshui, China
raw_author_name: Zhongjun Huang
raw_affiliation_strings: Department of Oncology, Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, China
Department of Oncology, Affiliated Hospital of Guizhou Medical University, Guiyang, China
Department of Oncology, Xingyi People's Hospital, Xingyi, China
Division of Oncology, School of Clinical Medicine, Guizhou Medical University, Guiyang, China
raw_author_name: Mi Zhang
raw_affiliation_strings: Department of Oncology, Dujiangyan Shoujia Hospital, Chengdu, China
Department of Oncology, Panzhou People's Hospital, Liupanshui, China
raw_author_name: Xian Liu
raw_affiliation_strings: Department of Oncology, Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, China
Department of Oncology, Affiliated Hospital of Guizhou Medical University, Guiyang, China
Department of Oncology, The First People's Hospital of Guiyang, Guiyang, China
Division of Oncology, School of Clinical Medicine, Guizhou Medical University, Guiyang, China
raw_author_name: Minfang Wang
raw_affiliation_strings: Department of Oncology, Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, China
Department of Oncology, Affiliated Hospital of Guizhou Medical University, Guiyang, China
Department of Oncology, The Second Affiliated Hospital of Guizhou Medical University, Kaili, China
Division of Oncology, School of Clinical Medicine, Guizhou Medical University, Guiyang, China
raw_author_name: Hongyan Luo
raw_affiliation_strings: Department of Oncology, Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, China
Department of Oncology, Affiliated Hospital of Guizhou Medical University, Guiyang, China
Department of Oncology, The Second Affiliated Hospital of Guizhou Medical University, Kaili, China
Division of Oncology, School of Clinical Medicine, Guizhou Medical University, Guiyang, China
raw_author_name: Fangyang Lu
raw_affiliation_strings: Department of Oncology, The Second Affiliated Hospital of Guizhou Medical University, Kaili, China
raw_author_name: Chuan Zhang
raw_affiliation_strings: Department of Pathology, The Second Affiliated Hospital of Guizhou Medical University, Kaili, China
raw_author_name: Xingxing Zhao
raw_affiliation_strings: Department of Pathology, The Second Affiliated Hospital of Guizhou Medical University, Kaili, China
raw_author_name: Shengfa Su
raw_affiliation_strings: Department of Oncology, Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, China
Department of Oncology, Affiliated Hospital of Guizhou Medical University, Guiyang, China
Division of Oncology, School of Clinical Medicine, Guizhou Medical University, Guiyang, China
raw_author_name: Jie Peng
raw_affiliation_strings: Department of Oncology, Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, China
Department of Oncology, Affiliated Hospital of Guizhou Medical University, Guiyang, China
Department of Oncology, The Second Affiliated Hospital of Guizhou Medical University, Kaili, China
Division of Oncology, School of Clinical Medicine, Guizhou Medical University, Guiyang, China